An interview with Founder & Chief Scientific Officer William Stimson in Drug Discovery World. Please read the interview below.
Scottish biotech company announces dramatic breakthrough in battle against COVID-19
• Drug also has potential to treat SARS, HIV, hepatitis and respiratory infection (RSV)• Earlier research shows drug is 15-20 times more potent than other interferons• Far fewer side effects than current treatments ILC Therapeutics has completed in vivo tests of its pioneering synthetic hybrid interferon Alfacyte™. The highly statistically